General corruption risk approaches applicable to the Health sector Overview of actors
(3) Diagnostic Tools Relevant for Assessing the health Sector’s Vulnerability to Corruption (UNDP) 2011a: 14-19).
- WHO’s Good Governance for Medicines program: An assessment tool to identify areas in the pharmaceutical sector that are vulnerable to corruption.
- World Bank Framework for Rapid Assessment in the Pharmaceutical Sector: Diagnostic tool that aims to help policy makers and development specialists. organize information about the pharmaceutical sector
- USAID methodology to test for corruption in the health sector: Examines key areas in a country’s healthcare system.
- International partnerships, using the example of Medicines Transparency Alliance (MeTA): Examines issues related to drug prices, quality, availability, promotion, transparency and accountability, and multi-stakeholder relationships.